Ab De Novo Sequencing - Global and China Top Players Market Share and Ranking 2023

Publication Month: Mar 2023 | No. of Pages: 140 Published By:
Single User License: US $ 3060
Corporate User License: US $ 5200

According to YH Research, the global market for Ab De Novo Sequencing should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China's market share increased from percent to percent. China Ab De Novo Sequencing market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Ab De Novo Sequencing market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Academic and Research Institutions grew percent to account for percent of the total market sales, and Pharmaceutical and Biotech Companies grew percent.
This report studies and analyses global Ab De Novo Sequencing status and future trends, to help determine the Ab De Novo Sequencing market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Ab De Novo Sequencing, and provides market size (US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Ab De Novo Sequencing market size, history data 2018-2023, and forecast data 2024-2029, (US$ million)
(2) Global Ab De Novo Sequencing by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(3) China Ab De Novo Sequencing by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(4) Global Ab De Novo Sequencing key consuming regions, consumption value and demand structure
(5) Ab De Novo Sequencing industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Nanjing Mingyan Biotechnology Co., Ltd.
Suzhou Jinweizhi Biotechnology Co., Ltd.
Beijing Baitai Parker Biotechnology Co., Ltd.
Biocompare
Abveris
Rapid Novor
GenScript
Absolute Antibody
Curia Global
ProteoGenix
CiteAb
BIOZOL
Market segment by Type, covers
Monoclonal Antibodies
Polyclonal Antibodies
Market segment by Application, can be divided into
Academic and Research Institutions
Pharmaceutical and Biotech Companies
Diagnostic and Clinical Laboratories
Other
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Ab De Novo Sequencing product scope, global consumption value, China consumption value, development opportunities, challenges, trends, and policies.
Chapter 2: Global Ab De Novo Sequencing market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 3: China Ab De Novo Sequencing market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 4: Ab De Novo Sequencing industry chain, upstream, medium-stream, and downstream.
Chapter 5: Segment by Type, consumption value, percent & CAGR, 2018-2029
Chapter 6: Segment by Application, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in country level, consumption value, percent & CAGR, 2018-2029
Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin.
Chapter 10: Conclusions

1 Market Overview
1.1 Ab De Novo Sequencing Definition
1.2 Global Ab De Novo Sequencing Market Size and Forecast
1.3 China Ab De Novo Sequencing Market Size and Forecast
1.4 China Percentage in Global Market
1.5 Ab De Novo Sequencing Market Size: China VS Global Growth Rate, 2018-2029
1.6 Ab De Novo Sequencing Market Dynamics
1.6.1 Ab De Novo Sequencing Market Drivers
1.6.2 Ab De Novo Sequencing Market Restraints
1.6.3 Ab De Novo Sequencing Industry Trends
1.6.4 Ab De Novo Sequencing Industry Policy
2 Global Leading Players and Market Share
2.1 By Revenue of Ab De Novo Sequencing, Global Market Share by Company, 2018-2023
2.2 Global Ab De Novo Sequencing Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Ab De Novo Sequencing Concentration Ratio
2.4 Global Ab De Novo Sequencing Mergers & Acquisitions, Expansion Plans
2.5 Global Ab De Novo Sequencing Major Companies Product Type
2.6 Head Office and Ab De Novo Sequencing Production Site of Key Manufacturer
3 China Leading Players, Market Share and Ranking
3.1 By Revenue of Ab De Novo Sequencing, China Market Share by Company, 2018-2023
3.2 China Ab De Novo Sequencing Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Industry Chain Analysis
4.1 Ab De Novo Sequencing Industry Chain
4.2 Ab De Novo Sequencing Upstream Analysis
4.2.1 Ab De Novo Sequencing Core Raw Materials
4.2.2 Main Manufacturers of Ab De Novo Sequencing Core Raw Materials
4.3 Midstream Analysis
4.4 Downstream Analysis
4.5 Ab De Novo Sequencing Production Mode
4.6 Ab De Novo Sequencing Procurement Model
4.7 Ab De Novo Sequencing Industry Sales Model and Sales Channels
4.7.1 Ab De Novo Sequencing Sales Model
4.7.2 Ab De Novo Sequencing Typical Distributors
5 Sights by Type
5.1 Ab De Novo Sequencing Classification
5.1.1 Monoclonal Antibodies
5.1.2 Polyclonal Antibodies
5.2 By Type, Global Ab De Novo Sequencing Consumption Value & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Ab De Novo Sequencing Consumption Value, 2018-2029
6 Sights by Application
6.1 Ab De Novo Sequencing Segment by Application
6.1.1 Academic and Research Institutions
6.1.2 Pharmaceutical and Biotech Companies
6.1.3 Diagnostic and Clinical Laboratories
6.1.4 Other
6.2 By Application, Global Ab De Novo Sequencing Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Ab De Novo Sequencing Consumption Value, 2018-2029
7 Sales Sights by Region
7.1 By Region, Global Ab De Novo Sequencing Consumption Value, 2018 VS 2022 VS 2029
7.2 By Region, Global Ab De Novo Sequencing Consumption Value, 2018-2029
7.3 North America
7.3.1 North America Ab De Novo Sequencing & Forecasts, 2018-2029
7.3.2 By Country, North America Ab De Novo Sequencing Market Size Market Share
7.4 Europe
7.4.1 Europe Ab De Novo Sequencing Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Ab De Novo Sequencing Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Ab De Novo Sequencing Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Ab De Novo Sequencing Market Size Market Share
7.6 South America
7.6.1 South America Ab De Novo Sequencing Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Ab De Novo Sequencing Market Size Market Share
7.7 Middle East & Africa
8 Sales Sights by Country Level
8.1 By Country, Global Ab De Novo Sequencing Market Size & CAGR, 2018 VS 2022 VS 2029
8.2 By Country, Global Ab De Novo Sequencing Consumption Value, 2018-2029
8.3 U.S.
8.3.1 U.S. Ab De Novo Sequencing Market Size, 2018-2029
8.3.2 By Type, U.S. Ab De Novo Sequencing Consumption Value Market Share, 2022 VS 2029
8.3.3 By Application, U.S. Ab De Novo Sequencing Consumption Value Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe Ab De Novo Sequencing Market Size, 2018-2029
8.4.2 By Type, Europe Ab De Novo Sequencing Consumption Value Market Share, 2022 VS 2029
8.4.3 By Application, Europe Ab De Novo Sequencing Consumption Value Market Share, 2022 VS 2029
8.5 China
8.5.1 China Ab De Novo Sequencing Market Size, 2018-2029
8.5.2 By Type, China Ab De Novo Sequencing Consumption Value Market Share, 2022 VS 2029
8.5.3 By Application, China Ab De Novo Sequencing Consumption Value Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan Ab De Novo Sequencing Market Size, 2018-2029
8.6.2 By Type, Japan Ab De Novo Sequencing Consumption Value Market Share, 2022 VS 2029
8.6.3 By Application, Japan Ab De Novo Sequencing Consumption Value Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Ab De Novo Sequencing Market Size, 2018-2029
8.7.2 By Type, South Korea Ab De Novo Sequencing Consumption Value Market Share, 2022 VS 2029
8.7.3 By Application, South Korea Ab De Novo Sequencing Consumption Value Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Ab De Novo Sequencing Market Size, 2018-2029
8.8.2 By Type, Southeast Asia Ab De Novo Sequencing Consumption Value Market Share, 2022 VS 2029
8.8.3 By Application, Southeast Asia Ab De Novo Sequencing Consumption Value Market Share, 2022 VS 2029
8.9 India
8.9.1 India Ab De Novo Sequencing Market Size, 2018-2029
8.9.2 By Type, India Ab De Novo Sequencing Consumption Value Market Share, 2022 VS 2029
8.9.3 By Application, India Ab De Novo Sequencing Consumption Value Market Share, 2022 VS 2029
8.10 Middle East & Africa
8.10.1 Middle East & Africa Ab De Novo Sequencing Market Size, 2018-2029
8.10.2 By Type, Middle East & Africa Ab De Novo Sequencing Consumption Value Market Share, 2022 VS 2029
8.10.3 By Application, Middle East & Africa Ab De Novo Sequencing Consumption Value Market Share, 2022 VS 2029
9 Company Profile
9.1 Nanjing Mingyan Biotechnology Co., Ltd.
9.1.1 Nanjing Mingyan Biotechnology Co., Ltd. Company Information, Head Office, Market Area and Industry Position
9.1.2 Nanjing Mingyan Biotechnology Co., Ltd. Company Profile and Main Business
9.1.3 Nanjing Mingyan Biotechnology Co., Ltd. Ab De Novo Sequencing Models, Specifications and Application
9.1.4 Nanjing Mingyan Biotechnology Co., Ltd. Ab De Novo Sequencing Revenue and Gross Margin, 2018-2023
9.1.5 Nanjing Mingyan Biotechnology Co., Ltd. Recent Developments
9.2 Suzhou Jinweizhi Biotechnology Co., Ltd.
9.2.1 Suzhou Jinweizhi Biotechnology Co., Ltd. Company Information, Head Office, Market Area and Industry Position
9.2.2 Suzhou Jinweizhi Biotechnology Co., Ltd. Company Profile and Main Business
9.2.3 Suzhou Jinweizhi Biotechnology Co., Ltd. Ab De Novo Sequencing Models, Specifications and Application
9.2.4 Suzhou Jinweizhi Biotechnology Co., Ltd. Ab De Novo Sequencing Revenue and Gross Margin, 2018-2023
9.2.5 Suzhou Jinweizhi Biotechnology Co., Ltd. Recent Developments
9.3 Beijing Baitai Parker Biotechnology Co., Ltd.
9.3.1 Beijing Baitai Parker Biotechnology Co., Ltd. Company Information, Head Office, Market Area and Industry Position
9.3.2 Beijing Baitai Parker Biotechnology Co., Ltd. Company Profile and Main Business
9.3.3 Beijing Baitai Parker Biotechnology Co., Ltd. Ab De Novo Sequencing Models, Specifications and Application
9.3.4 Beijing Baitai Parker Biotechnology Co., Ltd. Ab De Novo Sequencing Revenue and Gross Margin, 2018-2023
9.3.5 Beijing Baitai Parker Biotechnology Co., Ltd. Recent Developments
9.4 Biocompare
9.4.1 Biocompare Company Information, Head Office, Market Area and Industry Position
9.4.2 Biocompare Company Profile and Main Business
9.4.3 Biocompare Ab De Novo Sequencing Models, Specifications and Application
9.4.4 Biocompare Ab De Novo Sequencing Revenue and Gross Margin, 2018-2023
9.4.5 Biocompare Recent Developments
9.5 Abveris
9.5.1 Abveris Company Information, Head Office, Market Area and Industry Position
9.5.2 Abveris Company Profile and Main Business
9.5.3 Abveris Ab De Novo Sequencing Models, Specifications and Application
9.5.4 Abveris Ab De Novo Sequencing Revenue and Gross Margin, 2018-2023
9.5.5 Abveris Recent Developments
9.6 Rapid Novor
9.6.1 Rapid Novor Company Information, Head Office, Market Area and Industry Position
9.6.2 Rapid Novor Company Profile and Main Business
9.6.3 Rapid Novor Ab De Novo Sequencing Models, Specifications and Application
9.6.4 Rapid Novor Ab De Novo Sequencing Revenue and Gross Margin, 2018-2023
9.6.5 Rapid Novor Recent Developments
9.7 GenScript
9.7.1 GenScript Company Information, Head Office, Market Area and Industry Position
9.7.2 GenScript Company Profile and Main Business
9.7.3 GenScript Ab De Novo Sequencing Models, Specifications and Application
9.7.4 GenScript Ab De Novo Sequencing Revenue and Gross Margin, 2018-2023
9.7.5 GenScript Recent Developments
9.8 Absolute Antibody
9.8.1 Absolute Antibody Company Information, Head Office, Market Area and Industry Position
9.8.2 Absolute Antibody Company Profile and Main Business
9.8.3 Absolute Antibody Ab De Novo Sequencing Models, Specifications and Application
9.8.4 Absolute Antibody Ab De Novo Sequencing Revenue and Gross Margin, 2018-2023
9.8.5 Absolute Antibody Recent Developments
9.9 Curia Global
9.9.1 Curia Global Company Information, Head Office, Market Area and Industry Position
9.9.2 Curia Global Company Profile and Main Business
9.9.3 Curia Global Ab De Novo Sequencing Models, Specifications and Application
9.9.4 Curia Global Ab De Novo Sequencing Revenue and Gross Margin, 2018-2023
9.9.5 Curia Global Recent Developments
9.10 ProteoGenix
9.10.1 ProteoGenix Company Information, Head Office, Market Area and Industry Position
9.10.2 ProteoGenix Company Profile and Main Business
9.10.3 ProteoGenix Ab De Novo Sequencing Models, Specifications and Application
9.10.4 ProteoGenix Ab De Novo Sequencing Revenue and Gross Margin, 2018-2023
9.10.5 ProteoGenix Recent Developments
9.11 CiteAb
9.11.1 CiteAb Company Information, Head Office, Market Area and Industry Position
9.11.2 CiteAb Company Profile and Main Business
9.11.3 CiteAb Ab De Novo Sequencing Models, Specifications and Application
9.11.4 CiteAb Ab De Novo Sequencing Revenue and Gross Margin, 2018-2023
9.11.5 CiteAb Recent Developments
9.12 BIOZOL
9.12.1 BIOZOL Company Information, Head Office, Market Area and Industry Position
9.12.2 BIOZOL Company Profile and Main Business
9.12.3 BIOZOL Ab De Novo Sequencing Models, Specifications and Application
9.12.4 BIOZOL Ab De Novo Sequencing Revenue and Gross Margin, 2018-2023
9.12.5 BIOZOL Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer

Tables and Figures

Table 1. Ab De Novo Sequencing Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Ab De Novo Sequencing Market Restraints
Table 3. Ab De Novo Sequencing Market Trends
Table 4. Ab De Novo Sequencing Industry Policy
Table 5. Global Ab De Novo Sequencing Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Ab De Novo Sequencing Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Ab De Novo Sequencing Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Ab De Novo Sequencing Mergers & Acquisitions, Expansion Plans
Table 9. Global Ab De Novo Sequencing Major Companies Product Type
Table 10. Head Office and Area Served of Key Players
Table 11. China Ab De Novo Sequencing Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 12. China Ab De Novo Sequencing Revenue Market Share by Company, 2018-2023
Table 13. Global Key Players of Ab De Novo Sequencing Upstream (Raw Materials)
Table 14. Global Ab De Novo Sequencing Typical Customers
Table 15. Ab De Novo Sequencing Typical Distributors
Table 16. By Type, Global Ab De Novo Sequencing Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 17. By Application, Global Ab De Novo Sequencing Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 18. By Region, Global Ab De Novo Sequencing Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 19. By Region, Global Ab De Novo Sequencing Consumption Value, 2018-2029, US$ Million
Table 20. By Country, Global Ab De Novo Sequencing Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 21. By Country, Global Ab De Novo Sequencing Consumption Value, 2018-2029, US$ Million
Table 22. By Country, Global Ab De Novo Sequencing Consumption Value Market Share, 2018-2029
Table 23. Nanjing Mingyan Biotechnology Co., Ltd. Company Information, Head Office, Market Area and Industry Position
Table 24. Nanjing Mingyan Biotechnology Co., Ltd. Company Profile and Main Business
Table 25. Nanjing Mingyan Biotechnology Co., Ltd. Ab De Novo Sequencing Models, Specifications, and Application
Table 26. Nanjing Mingyan Biotechnology Co., Ltd. Ab De Novo Sequencing Revenue and Gross Margin, US$ Million, 2018-2023
Table 27. Nanjing Mingyan Biotechnology Co., Ltd. Recent Developments
Table 28. Suzhou Jinweizhi Biotechnology Co., Ltd. Company Information, Head Office, Market Area and Industry Position
Table 29. Suzhou Jinweizhi Biotechnology Co., Ltd. Company Profile and Main Business
Table 30. Suzhou Jinweizhi Biotechnology Co., Ltd. Ab De Novo Sequencing Models, Specifications, and Application
Table 31. Suzhou Jinweizhi Biotechnology Co., Ltd. Ab De Novo Sequencing Revenue and Gross Margin, US$ Million, 2018-2023
Table 32. Suzhou Jinweizhi Biotechnology Co., Ltd. Recent Developments
Table 33. Beijing Baitai Parker Biotechnology Co., Ltd. Company Information, Head Office, Market Area and Industry Position
Table 34. Beijing Baitai Parker Biotechnology Co., Ltd. Company Profile and Main Business
Table 35. Beijing Baitai Parker Biotechnology Co., Ltd. Ab De Novo Sequencing Models, Specifications, and Application
Table 36. Beijing Baitai Parker Biotechnology Co., Ltd. Ab De Novo Sequencing Revenue and Gross Margin, US$ Million, 2018-2023
Table 37. Beijing Baitai Parker Biotechnology Co., Ltd. Recent Developments
Table 38. Biocompare Company Information, Head Office, Market Area and Industry Position
Table 39. Biocompare Company Profile and Main Business
Table 40. Biocompare Ab De Novo Sequencing Models, Specifications, and Application
Table 41. Biocompare Ab De Novo Sequencing Revenue and Gross Margin, US$ Million, 2018-2023
Table 42. Biocompare Recent Developments
Table 43. Abveris Company Information, Head Office, Market Area and Industry Position
Table 44. Abveris Company Profile and Main Business
Table 45. Abveris Ab De Novo Sequencing Models, Specifications, and Application
Table 46. Abveris Ab De Novo Sequencing Revenue and Gross Margin, US$ Million, 2018-2023
Table 47. Abveris Recent Developments
Table 48. Rapid Novor Company Information, Head Office, Market Area and Industry Position
Table 49. Rapid Novor Company Profile and Main Business
Table 50. Rapid Novor Ab De Novo Sequencing Models, Specifications, and Application
Table 51. Rapid Novor Ab De Novo Sequencing Revenue and Gross Margin, US$ Million, 2018-2023
Table 52. Rapid Novor Recent Developments
Table 53. GenScript Company Information, Head Office, Market Area and Industry Position
Table 54. GenScript Company Profile and Main Business
Table 55. GenScript Ab De Novo Sequencing Models, Specifications, and Application
Table 56. GenScript Ab De Novo Sequencing Revenue and Gross Margin, US$ Million, 2018-2023
Table 57. GenScript Recent Developments
Table 58. Absolute Antibody Company Information, Head Office, Market Area and Industry Position
Table 59. Absolute Antibody Company Profile and Main Business
Table 60. Absolute Antibody Ab De Novo Sequencing Models, Specifications, and Application
Table 61. Absolute Antibody Ab De Novo Sequencing Revenue and Gross Margin, US$ Million, 2018-2023
Table 62. Absolute Antibody Recent Developments
Table 63. Curia Global Company Information, Head Office, Market Area and Industry Position
Table 64. Curia Global Company Profile and Main Business
Table 65. Curia Global Ab De Novo Sequencing Models, Specifications, and Application
Table 66. Curia Global Ab De Novo Sequencing Revenue and Gross Margin, US$ Million, 2018-2023
Table 67. Curia Global Recent Developments
Table 68. ProteoGenix Company Information, Head Office, Market Area and Industry Position
Table 69. ProteoGenix Company Profile and Main Business
Table 70. ProteoGenix Ab De Novo Sequencing Models, Specifications, and Application
Table 71. ProteoGenix Ab De Novo Sequencing Revenue and Gross Margin, US$ Million, 2018-2023
Table 72. ProteoGenix Recent Developments
Table 73. CiteAb Company Information, Head Office, Market Area and Industry Position
Table 74. CiteAb Company Profile and Main Business
Table 75. CiteAb Ab De Novo Sequencing Models, Specifications, and Application
Table 76. CiteAb Ab De Novo Sequencing Revenue and Gross Margin, US$ Million, 2018-2023
Table 77. CiteAb Recent Developments
Table 78. BIOZOL Company Information, Head Office, Market Area and Industry Position
Table 79. BIOZOL Company Profile and Main Business
Table 80. BIOZOL Ab De Novo Sequencing Models, Specifications, and Application
Table 81. BIOZOL Ab De Novo Sequencing Revenue and Gross Margin, US$ Million, 2018-2023
Table 82. BIOZOL Recent Developments
List of Figures
Figure 1. Ab De Novo Sequencing Picture
Figure 2. Global Ab De Novo Sequencing Consumption Value, (US$ million) & (2018-2029)
Figure 3. China Ab De Novo Sequencing Consumption Value, (US$ million) & (2018-2029)
Figure 4. By Consumption Value, China Ab De Novo Sequencing Market Share of Global, 2018-2029
Figure 5. Global Ab De Novo Sequencing Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 6. China Ab De Novo Sequencing Key Participants, Market Share, 2022
Figure 7. Ab De Novo Sequencing Industry Chain
Figure 8. Ab De Novo Sequencing Procurement Model
Figure 9. Ab De Novo Sequencing Sales Model
Figure 10. Ab De Novo Sequencing Sales Channels, Direct Sales, and Distribution
Figure 11. Monoclonal Antibodies
Figure 12. Polyclonal Antibodies
Figure 13. By Type, Global Ab De Novo Sequencing Consumption Value, 2018-2029, US$ Million
Figure 14. By Type, Global Ab De Novo Sequencing Consumption Value Market Share, 2018-2029
Figure 15. Academic and Research Institutions
Figure 16. Pharmaceutical and Biotech Companies
Figure 17. Diagnostic and Clinical Laboratories
Figure 18. Other
Figure 19. By Application, Global Ab De Novo Sequencing Consumption Value, 2018-2029, US$ Million
Figure 20. By Application, Global Ab De Novo Sequencing Consumption Value Market Share, 2018-2029
Figure 21. By Region, Global Ab De Novo Sequencing Consumption Value Market Share, 2018-2029
Figure 22. North America Ab De Novo Sequencing Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 23. By Country, North America Ab De Novo Sequencing Consumption Value Market Share, 2022
Figure 24. Europe Ab De Novo Sequencing Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 25. By Country, Europe Ab De Novo Sequencing Consumption Value Market Share, 2022
Figure 26. Asia Pacific Ab De Novo Sequencing Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 27. By Country/Region, Asia Pacific Ab De Novo Sequencing Consumption Value Market Share, 2022
Figure 28. South America Ab De Novo Sequencing Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 29. By Country, South America Ab De Novo Sequencing Consumption Value Market Share, 2022
Figure 30. Middle East & Africa Ab De Novo Sequencing Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 31. U.S. Ab De Novo Sequencing Consumption Value, 2018-2029, US$ Million
Figure 32. By Type, U.S. Ab De Novo Sequencing Consumption Value Market Share, 2022 VS 2029
Figure 33. By Application, U.S. Ab De Novo Sequencing Consumption Value Market Share, 2022 VS 2029
Figure 34. Europe Ab De Novo Sequencing Consumption Value, 2018-2029, US$ Million
Figure 35. By Type, Europe Ab De Novo Sequencing Consumption Value Market Share, 2022 VS 2029
Figure 36. By Application, Europe Ab De Novo Sequencing Consumption Value Market Share, 2022 VS 2029
Figure 37. China Ab De Novo Sequencing Consumption Value, 2018-2029, US$ Million
Figure 38. By Type, China Ab De Novo Sequencing Consumption Value Market Share, 2022 VS 2029
Figure 39. By Application, China Ab De Novo Sequencing Consumption Value Market Share, 2022 VS 2029
Figure 40. Japan Ab De Novo Sequencing Consumption Value, 2018-2029, US$ Million
Figure 41. By Type, Japan Ab De Novo Sequencing Consumption Value Market Share, 2022 VS 2029
Figure 42. By Application, Japan Ab De Novo Sequencing Consumption Value Market Share, 2022 VS 2029
Figure 43. South Korea Ab De Novo Sequencing Consumption Value, 2018-2029, US$ Million
Figure 44. By Type, South Korea Ab De Novo Sequencing Consumption Value Market Share, 2022 VS 2029
Figure 45. By Application, South Korea Ab De Novo Sequencing Consumption Value Market Share, 2022 VS 2029
Figure 46. Southeast Asia Ab De Novo Sequencing Consumption Value, 2018-2029, US$ Million
Figure 47. By Type, Southeast Asia Ab De Novo Sequencing Consumption Value Market Share, 2022 VS 2029
Figure 48. By Application, Southeast Asia Ab De Novo Sequencing Consumption Value Market Share, 2022 VS 2029
Figure 49. India Ab De Novo Sequencing Consumption Value, 2018-2029, US$ Million
Figure 50. By Type, India Ab De Novo Sequencing Consumption Value Market Share, 2022 VS 2029
Figure 51. By Application, India Ab De Novo Sequencing Consumption Value Market Share, 2022 VS 2029
Figure 52. Middle East & Africa Ab De Novo Sequencing Consumption Value, 2018-2029, US$ Million
Figure 53. By Type, Middle East & Africa Ab De Novo Sequencing Consumption Value Market Share, 2022 VS 2029
Figure 54. By Application, Middle East & Africa Ab De Novo Sequencing Consumption Value Market Share, 2022 VS 2029
Figure 55. Research Methodology
Figure 56. Breakdown of Primary Interviews
Figure 57. Bottom-up and Top-down Approaches
Figure 58. Top-down Approaches



Reason to Buy

  • Current and future of Service & Software Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Service & Software Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Service & Software Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Service & Software Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets